ANTICIPATED IMPACT OF LIVE BIOTHERAPEUTIC PRODUCTS ON FECAL MICROBIOTA TRANSPLANTATION (FMT) PRACTICE

被引:0
|
作者
Scharfen, James
Kim, Alison M.
Fredell, Lydia
Nersesova, Yanina
Serra, Sonya M.
Lewis, James D.
Wu, Gary D.
Laine, Loren
Kelly, Colleen R.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1603
引用
收藏
页码:S650 / S650
页数:1
相关论文
共 50 条
  • [31] Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?
    Pinn, D. M.
    Aroniadis, O. C.
    Brandt, L. J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (01): : 19 - 29
  • [32] The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review
    Zikou, Eva
    Koliaki, Chrysi
    Makrilakis, Konstantinos
    BIOMEDICINES, 2024, 12 (08)
  • [33] Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology
    Jamal, Rahima
    Messaoudene, Meriem
    de Figuieredo, Marina
    Routy, Bertrand
    SEMINARS IN IMMUNOLOGY, 2023, 67
  • [34] FACTORS PREDICTING RELAPSE OF CLOSTRIDIUM DIFFICLE COLITIS FOLLOWING FECAL MICROBIOTA TRANSPLANTATION (FMT)
    Tiwari, Abhinav
    Sharma, Himani
    Qamar, Khola
    Alastal, Yaseen
    Abdelfattah, Thaer
    Ammari, Zaid
    Simo, Hermann
    Khan, Mohammad
    Nawras, Ali
    GASTROENTEROLOGY, 2018, 154 (06) : S416 - S417
  • [35] Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report
    Shuyang Fang
    Colleen S. Kraft
    Tanvi Dhere
    Jahnavi Srinivasan
    Beth Begley
    David Weinstein
    Virginia O. Shaffer
    International Journal of Colorectal Disease, 2016, 31 : 1093 - 1094
  • [36] Impact of allogenic Fecal Microbiota Transplantation (FMT) on lipid parameters in patients with metabolic syndrome (MetS): a meta-analysis
    Wang, L.
    Zhang, L.
    Zhang, Y.
    Li, J. P.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] Impact of allogenic Fecal Microbiota Transplantation (FMT) on lipid parameters in patients with metabolic syndrome (MetS): a meta-analysis
    Wang, L.
    Zhang, L.
    Zhang, Y.
    Li, J. P.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [38] Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium
    Tseng, Ching-Hung
    Wong, Sunny
    Yu, Jun
    Lee, Yeong Yeh
    Terauchi, Jun
    Lai, Hsin-Chih
    Luo, Jiing-Chyuan
    Kao, Cheng Yen
    Yu, Sung-Liang
    Liou, Jyh-Ming
    Wu, Deng-Chyang
    Hou, Ming-Chih
    Wu, Ming-Shiang
    Wu, Jiunn-Jong
    Sung, Joseph J. Y.
    El-Omar, Emad M.
    Wu, Chun-Ying
    GUT, 2025,
  • [39] Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes
    Anand, Rohit
    Song, Yang
    Garg, Shashank
    Girotra, Mohit
    Sinha, Amitasha
    Sivaraman, Anita
    Phillips, Laila
    Dutta, Sudhir K.
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (04) : 1002 - 1008
  • [40] FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR THE TREATMENT OF IMMUNE-MEDIATED DIARRHEA AND COLITIS: A CASE SERIES
    Elkrief, Arielle
    Peled, Jonathan U.
    Hellmann, Matthew D.
    Chaft, Jamie E.
    Eng, Juliana
    Motzer, Robert
    Mendelsohn, Robin
    Chapman, Paul B.
    Faleck, David M.
    GASTROENTEROLOGY, 2021, 160 (06) : S17 - S17